Latest Regulatory Approval News

BCI Minerals reports robust progress in its Mardie Salt and Potash Project, achieving financial close on a $981 million debt facility and advancing construction beyond the halfway mark. The company maintains a strong focus on sustainability and safety as it targets first salt shipment in Q2 FY27.

Aroa Biosurgery has reported its first quarter of positive operating cash flow since listing on the ASX in 2020, alongside robust revenue growth projections and new regulatory approvals across key international markets.

Aruma Resources advances its exploration portfolio with standout assay results at Fiery Creek and strategic leadership changes, setting the stage for upcoming drilling campaigns.

Black Rock Mining has cleared key regulatory hurdles for POSCO's US$40 million equity injection and secured US$179 million in debt facilities, setting the stage for construction of its Mahenge Graphite Project in Tanzania.

Brightstar Resources has initiated ore haulage from its Laverton Hub under a key Ore Purchase Agreement, setting the stage for its first gold pour in March 2025 and positioning the company for growth amid record gold prices.

The Star Entertainment Group has agreed to sell its Sydney Event Centre assets to Foundation Theatres for $60 million, marking a strategic shift in its property portfolio.

29Metals Limited delivered a robust December Quarter 2024 update, marked by significant operational progress including high-grade copper discoveries at Europa and a successful debt refinancing that strengthens its financial footing.

Burley Minerals has reported robust iron assay results from its Cane Bore Iron Project, significantly enlarging prospective drilling areas and advancing towards a maiden drilling program pending heritage and regulatory approvals.

Asara Resources has resumed exploration activities at its flagship Kada Gold Project in Guinea, appointing key technical consultants and preparing for a targeted drilling program to upgrade its mineral resource estimate.

Opthea Limited has spotlighted Sozinibercept as a potential game-changer in wet age-related macular degeneration (AMD) therapy, presenting compelling clinical data and a clear path to U.S. market entry.

TrivarX has secured positive feedback from the FDA on its pivotal trial design for MEB-001, an AI-driven algorithm targeting major depressive episode screening via sleep study data. The company is advancing site collaborations to launch a large-scale US trial.

Mineral Commodities Ltd reports steady progress on its Munglinup graphite project and secures A$2.4 million in convertible loans, while navigating operational setbacks and a conditional sale of its Skaland asset.